Host
pattern recognition receptors (
PRRs) such as
Toll-like receptors (TLRs) detect viruses and other pathogens, inducing production of
cytokines that cause
inflammation and mobilize cells to control infection. Vaccinia virus (VACV) encodes
proteins that antagonize these host innate immune responses, and elucidating the mechanisms of action of these
viral proteins helped shed light on PRR signaling mechanisms. The VACV
virulence factor E3 is one of the most intensely studied VACV
proteins and has multiple effects on host cells, many of which cannot be explained by the currently known cellular targets of E3. Here, we report that E3 expression in human monocytes alters TLR2- and TLR8-dependent
cytokine induction, and particularly inhibits
interleukin (IL)-6. Using MS, we identified DExD/H-box helicase 9 (DHX9) as an E3 target. Although DHX9 has previously been implicated as a PRR for sensing
nucleic acid in dendritic cells, we found no role for DHX9 as a
nucleic acid-sensing PRR in monocytes. Rather, DHX9 suppression in these cells phenocopied the effects of E3 expression on TLR2- and TLR8-dependent
cytokine induction, in that DHX9 was required for all TLR8-dependent
cytokines measured, and for TLR2-dependent
IL-6. Furthermore, DHX9 also had a cell- and stimulus-independent role in
IL-6 promoter induction. DHX9 enhanced NF-κB-dependent
IL-6 promoter activation, which was directly antagonized by E3. These results indicate new roles for DHX9 in regulating
cytokines in innate immunity and reveal that VACV E3 disrupts innate immune responses by targeting of DHX9.